Nutraceutical Composition for Multimodal Prophylaxis

Abstract

A phytochemical and nutraceutical composition and method for protection against a wide spectrum of viral and bacterial infections, including Covid-19, and for treatment of established infection and infectious inflammation. The composition includes a novel combination of vitamin, mineral, nutraceutical and phytochemical supplements. The composition of supplements and method may be compounded as a pill, tablet, powder, capsule or liquid be taken orally one or more times per day, and parenteral including nasal sprays and inhalers. Vitamin C and vitamin E along with zinc complexed with pyrithione or citrate are used in conjunction with nutraceuticals and phytochemicals provided, respectively, as immune boosters and antiviral agents along with anti-inflammatory nutraceuticals and phytochemicals.

Claims

1. A phytochemical and nutraceutical composition to prevent or limit development of virally induced infections and inflammation including Covid-19, the composition comprising: an effective amount of a first vitamin; an effective amount of a second vitamin; an effective amount of a mineral; an effective amount of a nutraceutical compound for preventing or reducing viral and bacterial infections; and an effective amount of a nutraceutical compound for preventing or reducing viral and bacterial inflammations.

2. The composition of claim 1, wherein the first vitamin comprises vitamin C and the second vitamin comprises vitamin E; and wherein the mineral comprises zinc.

3. The composition of claim 1, wherein the mineral comprises: elemental zinc, zinc methionine, zinc pyrithione, zinc citrate, zinc gluconate, zinc picolinate, zinc sulfate, zinc acetate, or zinc orotate.

4. The composition of claim 1, wherein the nutraceutical compound for preventing or reducing viral and bacterial infections comprises one or more of the following anti-infectious phytochemicals: fulvic acid; Echinacea purpura extract; sage extract; Uncaria tomentosa extract; Black Elderberry extract or American Elderberry extract; Radix bupleuri extract; and pomegranate extract.

5. The composition of claim 1, wherein the nutraceutical compound for preventing or reducing viral and bacterial inflammations comprises: (i) two or more of the following anti-inflammatory nutraceuticals: Omega-3 fatty acids, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and alpha-lipoic acid; and (ii) two or more of the following anti-inflammatory phytochemicals: curcumin extract with piperine; green tea extract; Boswellia serrata extract comprising its most anti-inflammatory moiety, AKBA; resveratrol; Maritime pine bark; Commiphora myrrha extract; and cannabidiol (CBD).

6. A method for treating a patient having symptoms caused by a viral or bacterial infection and related inflammation, including Covid-19, comprising the step of: administering to the patient a composition comprising at least one nutraceutical and at least one phytochemical; wherein the at least one nutraceutical of the composition comprises: vitamin C, vitamin E, and zinc in any of its elemental, pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms; and wherein the at least one nutraceutical and the at least one phytochemical are anti-infectious and anti-inflammatory and prevent or reduce viral and bacterial infections and inflammations; wherein an effective amount of the at least one phytochemical and an effective amount of the at least one nutraceutical comprises: (i) two or more of the following anti-infectious phytochemicals: fulvic acid; Echinacea purpura extract; sage extract; Uncaria tomentosa extract; Black Elderberry extract or American Elderberry extract; pomegranate extract; and Radix bupleuri extract; and (ii) two or more of the following anti-inflammatory nutraceuticals: omega-3 fatty acids; eicosapentanoic acid (EPA); docosahexanoic acid (DHA); and alpha-lipoic acid; and (iii) two or more of the following anti-inflammatory phytochemicals: curcumin extract with piperine; green tea extract; Boswellia serrata extract, comprising 3-acetyl-11-keto-beta-boswellic acid (AKBA); resveratrol; Commiphora myrrha extract; Uncaria tomentosa extract; extract of maritime pine bark; and cannabidiol (CBD).

7. The method of claim 6, wherein the at least one nutraceutical of the composition further comprises zinc with the cofactor of methionine.

8. The method of claim 6, wherein the at least one nutraceutical of the composition comprises an effective amount of 1,000 mg of vitamin C; an effective amount of 200 mg of vitamin E; and an effective amount of 25 mg of zinc.

9. The method of claim 6, wherein the anti-infectious nutraceuticals of the composition comprise two or more of the following: 10 micrograms to 2,000 mg of fulvic acid; 10 micrograms to 1,500 mg of Echinacea purpura extract: 10 micrograms to 3,200 mg of sage extract; 10 micrograms to 2,000 mg of Cat's Claw extract; 10 micrograms to 2,000 mg of Black Elderberry extract or American Elderberry extract; 10 micrograms to 1,750 mg of pomegranate extract; and 10 micrograms to 1,000 mg of Radix bupleuri extract.

10. The method of claim 6, wherein the anti-inflammatory phytochemicals and nutraceuticals comprise: (i) two or more of the following anti-inflammatory nutraceuticals: 10 micrograms to 900 mg of omega-3 fatty acids, eicosapentanoic acid (EPA), and docosahexanoic acid (DHA); and 10 micrograms to 1,200 mg of alpha-lipoic acid; and (ii) two or more of the following anti-inflammatory phytochemicals: 10 micrograms to 1,200 mg of curcumin extract with piperine; 10 micrograms to 900 mg of green tea extract; 10 micrograms to 1,800 mg of Boswellia serrata extract, comprising its most anti-inflammatory moiety, 3-acetyl-11-keto-beta-boswellic acid (AKBA); 10 micrograms to 500 mg of resveratrol; 10 micrograms to 750 mg of Maritime pine bark extract; 10 micrograms to 800 mg of Commiphora myrrha extract; and 10 micrograms to 400 mg of Uncaria tomentosa extract; and 10 micrograms to 680 mg of cannabidiol (CBD).

11. A method of administering a composition to prevent or limit development of virally induced infections and inflammation, the method comprising the steps of: (a) preparing the composition for human consumption; (b) processing the composition as a tablet, powder, pill, capsule or liquid to be taken orally; and (c) administering the processed composition to a human being periodically.

12. A method for treating a patient having symptoms caused by a viral or bacterial infection and related inflammation, including Covid-19, comprising the step of administering a nutraceutical and phytochemical composition to the patient, including nasal spray and inhalers, said nutraceutical portion of the composition comprising vitamin C, vitamin E, and zinc in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms and appropriate nutraceutical and phytochemical components for preventing or reducing viral and bacterial infections and inflammations, wherein an effective amount of anti-infectious phytochemicals and an effective amount of anti-inflammatory nutraceuticals and phytochemicals include two or more of the following anti-infectious phytochemicals: a) fulvic acid; Echinacea purpura extract; sage extract; Uncaria tomentosa extract; Black Elderberry extract or American Elderberry extract; pomegranate extract; 10 microgram and Radix bupleuri extract; and two or more of the following anti-inflammatory nutraceuticals: b) Omega-3 fatty acids; eicosapentanoic acid (EPA) and docosahexanoic acid (DHA}; and Alpha-lipoic acid; and two or more of the following anti-inflammatory phytochemicals: c) curcumin extract with piperine; green tea extract; Boswellia serrata extract, containing three-acetyl-11-keto-beta-boswellic acid (AKBA); resveratrol; Commiphora myrrha extract; Uncaria tomentosa extract; extract of maritime pine bark; green tea extract; and d) cannabidiol (CBD).

13. The method as in claim 12, wherein, the step of adding a nutraceutical composition administering nutraceutical composition containing zinc with the cofactor of methionine.

14. The method as in claim 13, wherein the step of administering the nutraceutical composition in the effective amount of vitamin C 1000 mg; effective amount of vitamin E is 200 mg; and the effective amount of zinc is 25 mg.

15. The method as in claim 14, wherein the step of administering the effective amount of anti-infectious nutraceuticals in the composition include two or more of the following anti-infectious phytochemicals: a) 10 microgram-2000 mg fulvic acid extract; b) 10 microgram-1500 mg Echinacea purpura: c) 10 microgram-3200 mg Sage extract; d) 10 microgram-2000 mg Cat's Claw extract; and e) 10 microgram-2000 mg Black Elderberry extract or American Elderberry extract; f) 10 microgram-1750 mg pomegranate extract; and g) 10 microgram-1000 mg Radix bupleuri extract.

16. The method as in claim 15, wherein the step of administering the effective amount of anti-inflammatory phytochemicals and nutraceuticals include two or more of the following anti-inflammatory nutraceuticals: a) 10 micrograms-900 mg Omega-3 fatty acids, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and 10 micrograms-1200 mg Alpha-lipoic acid; and two or more of the following anti-inflammatory phytochemicals: b) 10 micrograms-1200 mg curcumin extract with piperine; c) 10 micrograms-900 mg Green Tea extract; d) 10 micrograms-1800 mg of Boswellia serrata, containing its most anti-inflammatory moiety, 3-acetyl-11-keto-beta-boswellic acid (AKBA); e) 10 micrograms-500 mg Resveratrol; f) 10 micrograms-750 mg extract of Maritime pine bark extract; g) 10 micrograms-800 mg Commiphora myrrha extract; and h) 10 micrograms-400 mg Uncaria tomentosa extract; and i) 10 micrograms-680 mg cannabidiol (CBD).

17. A phytochemical and nutraceutical composition to prevent or limit development of virally induced infections and inflammation, including Covid-19, comprising: an effective amount of first and second vitamins; an effective amount of a mineral; an effective amount of a nutraceutical and a phytochemical compound for preventing or reducing viral and bacterial infections; and an effective amount of a nutraceutical and phytochemical compound preventing or reducing viral and bacterial inflammations.

18. A phytochemical/nutraceutical composition as in claim 17, wherein: said first vitamin is vitamin C and said second vitamin is vitamin E; and said mineral is zinc in any of its pyrithione, citrate, gluconate, picolinate, sulfate, acetate, or orotate forms.

19. A phytochemical/nutraceutical composition as in claim 18, wherein: said effective amount of a nutraceutical compound for preventing or reducing viral and bacterial infections including two or more of the following anti-infectious phytochemicals: extracted fulvic acid; Echinacea purpura extract; Sage extract; Uncaria tomentosa extract; and Black Elderberry extract or American Elderberry extract; Radix bupleuri extract; pomegranate extract.

20. A nutraceutical composition as in claim 19, wherein: said effective amount of said nutritional compound preventing or reducing viral and bacterial inflammations includes two or more of the following anti-inflammatory nutraceuticals: Omega-3 fatty acids, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and Alpha-lipoic acid; And two or more of the following anti-inflammatory phytochemicals: Curcumin extract with piperine; Green Tea extract; Boswellia serrata extract, containing its most anti-inflammatory moiety, AKBA; Resveratrol: Maritime pine bark; Commiphora myrrha extract, and cannabidiol (CBD).

Description

DETAILED DESCRIPTION

[0036] For the purposes of this specification, the word nutraceutical refers to a food item, or a part of a food item, that offers medical health benefits, including prevention and/or treatment of disease. More particularly, a nutraceutical is a material that is: [0037] a. a dietary supplement containing a nutritive bioactive compound; or [0038] b. a biologically active process or process material derived from a vitamin, mineral, and herbal/organic supplements plant, fungus, and animal, or a portion thereof; where the precise composition of the biologically active process or unprocessed material may be undetermined.

[0039] The word phytochemical refers to non-nutritive organic components of plants that are thought to promote human health. Unlike the traditional nutrients (protein, fat, carbohydrates, vitamins and minerals), phytochemicals are not essential for life but have a wide range of therapeutic applications. Phytochemicals, within the parent plant, help it resist microbial attack by fungi, bacteria, and viruses.

[0040] Examples of a biologically active process material may include a finely chopped, powdered, pureed, or cooked material derived from plant or animal tissue, or an extract of plant or animal tissue. These agents are useful for accelerating improved immune function; and they include extracts from various plants and mixtures thereof.

[0041] A novel and unique combination of vitamin, mineral and herbal/organic supplements (phytochemicals and nutraceuticals) in one formulary forming one or more compositions and methods for the purpose of fortifying the innate (cellular) and adaptive (hormonal) components of the immune system against bacterial and viral infection, and their propagation, transmission and effects.

[0042] Also included in the formulary compositions are two or more natural, herbal or other organic anti-inflammatory substances for the suppression of tissue inflammation, especially in the lungs. The formulary thereby provides multimodal nutraceutical and phytochemical protection against acquisition of infection and against deleterious effects of inflammation in the lungs. The formulary is available in both oral and parenteral forms, including nasal sprays and inhalers.

[0043] In a preferred embodiment, the formulary composition contains: [0044] 5 mg-50 mg zinc in any of its pyrithione, citrate, gluconate, picolinate, acetate, sulfate or orotate forms, or with the cofactor methionine; [0045] 10 mg-2000 mg vitamin C; [0046] 5 mg-1000 mg vitamin E; [0047] two or more of the following wide-spectrum anti-infectious phytochemicals: [0048] 10 micrograms-2000 mg extracted fulvic acid; [0049] 10 micrograms-1000 mg Radix bupleuri extract; [0050] 10 micrograms-1000 mg Uncaria tomentosa extract; [0051] 10 micrograms-1750 mg pomegranate extract; [0052] 10 micrograms-2000 mg Black Elderberry extract or American Elderberry extract; [0053] 10 micrograms-3200 mg Sage extract; [0054] 10 micrograms-1500 mg Echinacea purpura extract; and [0055] two anti-inflammatory nutraceuticals: [0056] 10 micrograms-900 mg Omega-3 fatty acids, eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); [0057] 10 micrograms-1200 mg Alpha-lipoic acid; and [0058] two or more of the following anti-inflammatory phytochemicals [0059] 10 micrograms-1800 mg Boswellia serrata extract, containing its most anti-inflammatory moiety, 3-acetyl-11-keto--boswellic acid (AKBA); [0060] 10 micrograms-750 mg Maritime pine bark extract; [0061] 10 micrograms-400 mg Uncaria tomentosa extract; [0062] 10 micrograms-800 mg Commiphora myrrha extract; [0063] 10 micrograms-500 mg Resveratrol; [0064] 10 micrograms-1200 mg Curcumin extract with piperine; [0065] 10 micrograms-900 mg Green Tea extract; [0066] 10 micrograms-680 mg Cannabidiol (CBD).

[0067] Any of the listed wide-spectrum anti-infectious nutraceuticals and phytochemicals permutated with any of the listed anti-inflammatory nutraceuticals and phytochemicals will confer five levels of anti-infectious protection, including white blood cell fortification and activation, virucidal-bactericidal activity, enhancement of antibody production, anti-oxidant activity and anti-inflammatory activity. The oral formulary, capsule or other, is enteric-coated to prevent breakdown by gastric acid and permit delivery of unaltered nutraceuticals and phytochemicals to the duodenum for absorption.

[0068] The method of the invention includes the steps of providing a patient with an antiviral and/or anti-inflammatory capsule or other oral form, parenteral administration, and nasal sprays and inhalers. containing a nutraceutical and phytochemical composition described herein to treat viral infections and inflammations resulting therefrom, once or more daily, in prescribed amounts, depending on the condition of the patient.

[0069] Although the present invention has been described in detail with particular reference in a preferred embodiment thereof, it should be understood that the invention is capable of other different embodiments, and its details are capable of modifications in various obvious respects. As is readily apparent to those skilled in the art, variations and modifications can be affected while remaining within the spirit and scope of the invention. Accordingly, the foregoing disclosure description is for illustrative purposes only and do not in any way limit the invention which is defined only by the claims.